EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma

Amir Hossein Karimi, Peter Yf Zeng, Matthew Cecchini, John W Barrett, Harrison Pan, Shengjie Ying, Nhi Le, Joe S Mymryk, Laurie E Ailles, Anthony C Nichols iD

European Thyroid Journal · 01.06.2025 · 14 (3)

DOI: 10.1530/etj-25-0057 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Thyroid Journal, online erschienen am 21.05.2025. Verfasst von Amir Hossein Karimi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head & Neck Surgery, Western University, London, Ontario, Canada. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Thyroid Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anaplastic thyroid carcinoma (ATC) is among the most daunting entities in clinical oncology. Large-scale genomic studies of thyroid cancer within the last decade have uncovered a distinct set of recurrent somatic alterations implicated in the development, aggressiveness, and treatment resistance of ATC. The sequence of events leading to the development of ATC commonly begins with a tumorigenic mutation that constitutively activates the mitogen-activated protein kinase (MAPK) pathway, giving rise to indolent entities such as well-differentiated papillary or follicular thyroid carcinomas. This is followed by recurring alterations that drive oncogenic properties such as enhanced proliferation, genomic instability, replicative immortality, and dedifferentiation, culminating in the emergence of highly aggressive ATC tumors. The truncal MAPK-activating events present therapeutic opportunities, as small molecule inhibitors against key components of this pathway are available. Indeed, genotype-guided targeting of the MAPK pathway is now the standard of care for subgroups of ATC patients, and further efforts exploring additional MAPK inhibitors and the combination of immune checkpoint blockade with MAPK inhibition are overcoming resistance to the current targeted therapies in the clinic and expanding our arsenal against this disease. In this review, we summarize the current understanding of the genomic landscape of ATC, discuss the biological and clinical ramifications of recurring aberrations, and provide an overview of the opportunities and challenges in the clinical management of this lethal malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Carcinoma, AnaplasticThyroid NeoplasmsHumansProtein Kinase InhibitorsMAP Kinase Signaling SystemMutationMolecular Targeted Therapy

Stichwörter der Autor:innen

anaplastic thyroid carcinomagenomicsimmunotherapytargeted therapy

Substanzen

Protein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Otolaryngology - Head & Neck Surgery, Western University, London, Ontario, Canada.
  • Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
  • Department of Oncology, Western University, London, Ontario, Canada.
  • Department of Microbiology & Immunology, Western University, London, Ontario, Canada.
  • Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Anthony C Nichols

Förderung

  • CIHR

Zitieren

APA

Karimi, A. H., Zeng, P. Y., Cecchini, M., Barrett, J. W., Pan, H., Ying, S., Le, N., Mymryk, J. S., Ailles, L. E., & Nichols, A. C. (2025). NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma. European Thyroid Journal, 14(3). https://doi.org/10.1530/etj-25-0057

Vancouver

Karimi AH, Zeng PY, Cecchini M, Barrett JW, Pan H, Ying S, et al. NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma. European Thyroid Journal. 2025;14(3). doi:10.1530/etj-25-0057

BibTeX
@article{Karimi2025,
  author = {Karimi, Amir Hossein and Zeng, Peter Yf and Cecchini, Matthew and Barrett, John W and Pan, Harrison and Ying, Shengjie and Le, Nhi and Mymryk, Joe S and Ailles, Laurie E and Nichols, Anthony C},
  title = {NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma},
  journal = {European Thyroid Journal},
  year = {2025},
  volume = {14},
  number = {3},
  doi = {10.1530/etj-25-0057}
}
Kostenlos starten →